<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">19929031</PMID>
        <DateCompleted>
            <Year>2010</Year>
            <Month>07</Month>
            <Day>29</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1179-1969</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>26</Volume>
                    <Issue>12</Issue>
                    <PubDate>
                        <Year>2009</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Drugs &amp; aging</Title>
                <ISOAbbreviation>Drugs Aging</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Polypharmacy status as an indicator of mortality in an elderly population.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1039-48</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.2165/11319530-000000000-00000</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Increased use of drugs has raised concern about the risks of polypharmacy in elderly populations. Adverse outcomes, such as hospitalizations and falls, have been shown to be associated with polypharmacy. So far, little information is available on the association between polypharmacy status and mortality.</AbstractText>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess whether polypharmacy (six to nine drugs) or excessive polypharmacy (ten or more drugs) could be indicators of mortality in elderly persons.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">This was a population-based cohort study conducted between 1998 and 2003 with mortality follow-up through to 2007. The data in this study were derived from the population-based Kuopio 75+ Study, which involved elderly persons aged&gt;or=75 years living in the city of Kuopio, Finland. The initial sample (sample frame n=4518, random sample n=700) was drawn from the population register. For the purpose of this study, two separate analyses were carried out. In the first phase, participants (aged&gt;or=75 years, n=601) were followed from 1998 (baseline) to 2002. In the second phase, survivors (aged&gt;or=80 years, n=339) were followed from 2003 to 2007. Current medications were determined from drug containers and prescriptions during interviews conducted by a trained nurse. The Kaplan-Meier method and Cox proportional hazards regression were used to examine the association between polypharmacy status and mortality.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">In the first phase, 28% (n=167) belonged to the excessive polypharmacy group, 33% (n=200) to the polypharmacy group, and the remaining 39% (n=234) to the non-polypharmacy (0-5 drugs) group. The corresponding figures in the second phase were 28% (n=95), 39% (n=132) and 33% (n=112), respectively. The mortality rate was 37% in the first phase and 40% in the second phase. In both phases, the survival curves showed a significant difference in all-cause mortality between the three polypharmacy groups. In the first phase, the univariate model showed an association between excessive polypharmacy and mortality (hazard ratio [HR] 2.53, 95% CI 1.83, 3.48); however, after adjustment for demographics and other variables measuring functional and cognitive status, this association did not remain statistically significant (HR 1.28, 95% CI 0.86, 1.91). In the second phase, the association between excessive polypharmacy and mortality (HR 2.23, 95% CI 1.21, 4.12) remained significant after adjustments. Age, male sex and dependency according to the Instrumental Activities of Daily Living screening instrument were associated with mortality in both phases.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study points to the importance of excessive polypharmacy as an indicator for mortality in elderly persons. This association needs to be confirmed following adjustment for co-morbidities.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Jyrkk√§</LastName>
                    <ForeName>Johanna</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Public Health and Clinical Nutrition, University of Kuopio, Kuopio, Finland. johanna.jyrkka@uef.fi</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Enlund</LastName>
                    <ForeName>Hannes</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Korhonen</LastName>
                    <ForeName>Maarit J</ForeName>
                    <Initials>MJ</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sulkava</LastName>
                    <ForeName>Raimo</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hartikainen</LastName>
                    <ForeName>Sirpa</ForeName>
                    <Initials>S</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D003160">Comparative Study</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>New Zealand</Country>
            <MedlineTA>Drugs Aging</MedlineTA>
            <NlmUniqueID>9102074</NlmUniqueID>
            <ISSNLinking>1170-229X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009026" MajorTopicYN="N">Mortality</DescriptorName>
                <QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019338" MajorTopicYN="Y">Polypharmacy</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName>
                <QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2009</Year>
                <Month>11</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2009</Year>
                <Month>11</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2010</Year>
                <Month>7</Month>
                <Day>30</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">19929031</ArticleId>
            <ArticleId IdType="pii">5</ArticleId>
            <ArticleId IdType="doi">10.2165/11319530-000000000-00000</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Am Geriatr Soc. 2006 Oct;54(10):1516-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17038068</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 1997 Oct 25;315(7115):1096-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9366745</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drug Saf. 2007;30(10):911-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17867728</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Geriatr Pharmacother. 2007 Dec;5(4):317-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18179989</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Pharmacother. 2002 May;36(5):797-803</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11978154</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Clin Pharmacol. 2007 Feb;63(2):187-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16939529</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Fam Pract. 2000 Jun;17(3):261-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10846147</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Geriatr Soc. 2009 Jan;57(1):62-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19054196</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Ther. 2008 Feb;30(2):419-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18343279</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Geriatr Pharmacother. 2006 Mar;4(1):36-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16730619</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Age Ageing. 2005 Nov;34(6):626-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16267190</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 1998 Apr 15;279(15):1187-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9555758</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Fam Pract. 2007 Feb;24(1):14-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17164234</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Gen Pract. 2007 Sep;57(542):723-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17761060</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drugs Aging. 2003;20(11):817-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12964888</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Geriatr. 2008 Dec 22;8:34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19102751</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Clin Pharmacol. 1999 Sep;55(7):533-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10501824</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Clin Pharmacol. 2006 Feb;62(2):151-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16408226</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Geriatr Pharmacother. 2007 Dec;5(4):345-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18179993</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Acad Nurse Pract. 2005 Apr;17(4):123-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15819637</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Age Ageing. 1999 Sep;28(5):429-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10529035</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Gen Pract. 2006 Jul;56(528):504-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16834876</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Psychiatr Res. 1975 Nov;12(3):189-98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1202204</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Clin Pharmacol. 2008 Jan;65(1):130-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17578478</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Geriatr Soc. 2006 Apr;54(4):598-605</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16686869</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Clin Pharmacol. 2006 Feb;61(2):218-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16433876</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Clin Pharmacol. 1997;53(1):7-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9349923</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Intern Med. 2005 Jan 10;165(1):68-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15642877</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gerontologist. 1969 Autumn;9(3):179-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">5349366</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Epidemiol. 2000 Apr 1;151(7):676-88</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10752795</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Med Qual. 2008 Mar-Apr;23(2):115-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18305099</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Geriatr Soc. 2005 Sep;53(9):1518-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16137281</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Pharmacother. 1997 Jul-Aug;31(7-8):823-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9220038</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gerontol A Biol Sci Med Sci. 2006 Feb;61(2):170-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16510861</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gerontology. 2006;52(2):92-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16508316</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gerontol A Biol Sci Med Sci. 2000 Oct;55(10):M554-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11034227</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Pharm Ther. 2007 Oct;32(5):469-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17875113</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Age Ageing. 2008 Jan;37(1):96-101</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17933759</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>